The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
Open accessAbstract
Angiotensin-converting enzyme inhibitors (ACEi) improve cardiac function and remodeling and prolong survival in patients with heart failure (HF). Blockade of the renin-angiotensin system (RAS) with an angiotensin II type 1 receptor antagonist (AT1-ant) may have a similar beneficial effect. In addition to inhibition of the RAS, ACEi may also act by inhibiting kinin destruction, whereas AT1-ant may block the RAS at the level of the AT1 receptor and activate the angiotensin II type 2 (AT2) receptor. Using a model of HF induced by myocardial infarction (MI) in rats, we studied the role of kinins in the cardioprotective effect of ACEi. We also investigated whether an AT1-ant has a similar effect and whether these effects are partly due to activation of the AT2 receptor. Two months after MI, rats were treated for 2 mo with: (a) vehicle; (b) the ACEi ramipril, with and without the B2 receptor antagonist icatibant (B2-ant); or (c) an AT1-ant with and without an AT2-antagonist (AT2-ant) or B2-ant. Vehicle-treated rats had a significant increase in left ventricular end-diastolic (LVEDV) and end-systolic volume (LVESV) as well as interstitial collagen deposition and cardiomyocyte size, whereas ejection fraction was decreased. Left ventricular remodeling and cardiac function were improved by the ACEi and AT1-ant. The B2-ant blocked most of the cardioprotective effect of the ACEi, whereas the effect of the AT1-ant was blocked by the AT2-ant. The decreases in LVEDV and LVESV caused by the AT1-ant were also partially blocked by the B2-ant. We concluded that (a) in HF both ACEi and AT1-ant have a cardioprotective effect, which could be due to either a direct action on the heart or secondary to altered hemodynamics, or both; and (b) the effect of the ACEi is mediated in part by kinins, whereas that of the AT1-ant is triggered by activation of the AT2 receptor and is also mediated in part by kinins. We speculate that in HF, blockade of AT1 receptors increases both renin and angiotensins; these angiotensins stimulate the AT2 receptor, which in turn may play an important role in the therapeutic effect of the AT1-ant via kinins and other autacoids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Swedberg, K., & Kjekshus, J. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Julian, D. G., Moss, A. J., Murray, G. D., Poole-Wilson, P. A., Simoons, M. L., Ball, S., Bender, N., Cleland, J. G. F., Dl, C., Pj, C., et al. (1993) · PubMed · Cited by 2,144
Garg, R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520420066040 · Cited by 1,771
Sadoshima, J.-I., Xu, Y., Slayter, H. S., & Izumo, S. (1993) · Cell · doi:10.1016/0092-8674(93)90541-w · Cited by 1,348
Stoll, M., Steckelings, U. M., Paul, M., Bottari, S. P., Metzger, R., & Unger, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117710 · Cited by 906
Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor
Ichiki, T., Labosky, P. A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., Niimura, F., Ichikawa, I., Hogan, B. L. M., & lnagami, T. (1995) · Nature · doi:10.1038/377748a0 · Cited by 858
Preliminary biochemical characterization of two angiotensin II receptor subtypes
Whitebread, S., Mele, M., Kamber, B., & de Gasparo, M. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92133-5 · Cited by 777
Nakajima, M., Hutchinson, H. G., Fujinaga, M., Hayashida, W., Morishita, R., Zhang, L., Horiuchi, M., Pratt, R. E., & Dzau, V. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10663 · Cited by 680
THEACUTEINFARCTIONRAMIPRILEFFI (1993) · The Lancet · doi:10.1016/0140-6736(93)92693-n · Cited by 547
Carini, D. J., Duncia, J. V., Aldrich, P. E., Chiu, A. T., Johnson, A. L., Pierce, M. E., Price, W. A., Santella, J. B., & Wells, G. J. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00112a031 · Cited by 435
Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction.
Nio, Y., Matsubara, H., Murasawa, S., Kanasaki, M., & Inada, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117675 · Cited by 435
The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence.
Lindpaintner, K., & Ganten, D. (1991) · Circulation Research · doi:10.1161/01.res.68.4.905 · Cited by 422
Angiotensin-(1-7) Dilates Canine Coronary Arteries Through Kinins and Nitric Oxide
Brosnihan, K. B., Li, P., & Ferrario, C. M. (1996) · Hypertension · doi:10.1161/01.hyp.27.3.523 · Cited by 404
Fletcher, P. J., Pfeffer, J. M., Pfeffer, M. A., & Braunwald, E. (1981) · Circulation Research · doi:10.1161/01.res.49.3.618 · Cited by 362
Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells
Baker, K. M., & Aceto, J. F. (1990) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1990.259.2.h610 · Cited by 353
Liebson, P. R., Grandits, G. A., Dianzumba, S., Prineas, R. J., Grimm, R. H., Neaton, J. D., & Stamler, J. (1995) · Circulation · doi:10.1161/01.cir.91.3.698 · Cited by 326
Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
Campbell, D. J., Kladis, A., & Duncan, A. M. (1994) · Hypertension · doi:10.1161/01.hyp.23.4.439 · Cited by 317
Siragy, H. M., & Carey, R. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118630 · Cited by 314
Structural Basis for Heart Failure: Ventricular Remodeling and Its Pharmacological Inhibition
Cohn, J. N. (1995) · Circulation · doi:10.1161/01.cir.91.10.2504 · Cited by 297
Gottlieb, S. S., Dickstein, K., Fleck, E., Kostis, J., Levine, T. B., LeJemtel, T., & DeKock, M. (1993) · Circulation · doi:10.1161/01.cir.88.4.1602 · Cited by 291
Suzuki, J., Matsubara, H., Urakami, M., & Inada, M. (1993) · Circulation Research · doi:10.1161/01.res.73.3.439 · Cited by 283
Laitinen, L. (1987) · The Histochemical Journal · doi:10.1007/bf01680633 · Cited by 271
Coronary Kinin Generation Mediates Nitric Oxide Release After Angiotensin Receptor Stimulation
Seyedi, N., Xu, X., Nasjletti, A., & Hintze, T. H. (1995) · Hypertension · doi:10.1161/01.hyp.26.1.164 · Cited by 254
Angiotensin converting enzyme inhibition in patients with congestive heart failure.
Gavras, H., Faxon, D. P., Berkoben, J., Brunner, H. R., & Ryan, T. J. (1978) · Circulation · doi:10.1161/01.cir.58.5.770 · Cited by 244
Farhy, R. D., Carretero, O. A., Ho, K. L., & Scicli, A. G. (1993) · Circulation Research · doi:10.1161/01.res.72.6.1202 · Cited by 229
Self-citationLopez, J. J., Lorell, B. H., Ingelfinger, J. R., Weinberg, E. O., Schunkert, H., Diamant, D., & Tang, S. S. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.267.2.h844 · Cited by 202
Dickstein, K., Chang, P., Willenheimer, R., Haunsø, S., Remes, J., Hall, C., & Kjekshus, J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)80020-h · Cited by 194
Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression.
Everett, A. D., Tufro-McReddie, A., Fisher, A., & Gomez, R. A. (1994) · Hypertension · doi:10.1161/01.hyp.23.5.587 · Cited by 194
[Sar1]angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells
Aceto, J. F., & Baker, K. M. (1990) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1990.258.3.h806 · Cited by 186
Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.
Gohlke, P., Linz, W., Schölkens, B. A., Kuwer, I., Bartenbach, S., Schnell, A., & Unger, T. (1994) · Hypertension · doi:10.1161/01.hyp.23.4.411 · Cited by 180
von Lutterotti, N., Catanzaro, D. F., Sealey, J. E., & Laragh, J. H. (1994) · Circulation · doi:10.1161/01.cir.89.1.458 · Cited by 179
The Kallikrein‐Kinin System as a Regulator of Cardiovascular and Renal Function
Rhaleb, N., Yang, X., & Carretero, O. A. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100053 · Cited by 168
Self-citationMcDonald, K. M., Mock, J., D’Aloia, A., Parrish, T., Hauer, K., Francis, G., Stillman, A., & Cohn, J. N. (1995) · Circulation · doi:10.1161/01.cir.91.7.2043 · Cited by 158
Effects of Losartan on Angiotensin and Bradykinin Peptides and Angiotensin-Converting Enzyme
Campbell, D. J., Kladis, A., & Valentijn, A. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199508000-00009 · Cited by 145
A local kallikrein-kinin system is present in rat hearts.
Nolly, H. L., Carbini, L. A., Scicli, G. M., et al. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.919 · Cited by 142
Reduction of Myocardial Infarct Size in Rabbits by Ramiprilat
Hartman, J. C., Wall, T. M., Hullinger, T. G., & Shebuski, R. J. (1993) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199306000-00022 · Cited by 141
Liu, Y.-H., Yang, X.-P., Sharov, V. G., Sigmon, D. H., Sabbah, H. N., & Carretero, O. A. (1996) · Hypertension · doi:10.1161/01.hyp.27.1.7 · Cited by 141
Self-citationSubtype 2 of angiotensin II receptors controls pressure-natriuresis in rats.
Lo, M., Liu, K.-L., Lantelme, P., & Sassard, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117792 · Cited by 138
(1993) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1016/1053-0770(93)90231-9 · Cited by 136
Chronic heart failure induced by coronary artery ligation in Lewis inbred rats
Liu, Y., Yang, X. P., Nass, O., Sabbah, H. N., Peterson, E. L., & Carretero, O. A. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.272.2.h722 · Cited by 124
Self-citationRole of Bradykinin in the Cardiac Effects of Angiotensin-Converting Enzyme Inhibitors
Linz, W., & Schölkens, B. A. (1992) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199200209-00015 · Cited by 111
McDonald, K., Garr, M. D., Carlyle, P. F., Francis, G. S., Hauer, K. M., Hunter, D. W., Parish, T. R., Stillman, A. E., & Cohn, J. N. (1994) · Circulation · doi:10.1161/01.cir.90.6.3034 · Cited by 105
Characterization of Bradykinin B2Receptors in Adult Myocardium and Neonatal Rat Cardiomyocytes
Minshall, R. D., Nakamura, F., Becker, R. P., & Rabito, S. F. (1995) · Circulation Research · doi:10.1161/01.res.76.5.773 · Cited by 90
Stauss, H. M., Zhu, Y., Redlich, T., Adamiak, D., Mott, A., Kregel, K. C., & Unger, T. (1994) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679400100311 · Cited by 89
Kallikrein release by vascular tissue
Nolly, H. L., Carretero, O. A., & Scicli, A. G. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.265.4.h1209 · Cited by 64
Self-citationLamontagne, D., Nadeau, R. A., & Adam, A. A. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16357.x · Cited by 56
Preventive treatment of asymptomatic left ventricular dysfunction following myocardial infarction
Sharpe, N., Murphy, J., Smith, H., & Hannan, S. (1990) · European Heart Journal · doi:10.1093/eurheartj/11.suppl_b.147 · Cited by 49
Bradykinin prevents left ventricular hypertrophy in rats
Linz, W., Wiemer, G., & lkens, B. A. S. (1993) · Journal of Hypertension · doi:10.1097/00004872-199312050-00027 · Cited by 41
Renal effects of Fab fragments of kinin antibodies on deoxycorticosterone acetate-salt-treated rats.
Tomiyama, H., Scicli, A. G., Scicli, G. M., et al. (1990) · Hypertension · doi:10.1161/01.hyp.15.6.761 · Cited by 30
Cited by
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
Forette, F. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.18.2046 · Cited by 898
TGF-?1 and angiotensin networking in cardiac remodeling
ROSENKRANZ, S. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.04.030 · Cited by 683
Pathophysiology of Myocardial Infarction
Frangogiannis, N. G. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c150006 · Cited by 618
Metadata
- Authors
- Liu, Y. H., Yang, X. P., Sharov, V. G., Nass, O., Sabbah, H. N., Peterson, E., & Carretero, O. A.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-04-15
- Volume
- 99
- Issue
- 8
- Pages
- 1926-1935
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2058755393
- Cited by
- 603
- References
- 51
- FWCI
- 32.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.